TCRX tscan.com Sotuvning yalpi rentabelligi

TScan Therapeutics (TCRX) kompaniyasining rasmiy ramzlari

TScan Therapeutics (TCRX) shaxsiylashtirilgan dori vositalarini kengaytirish risklarini o'zining noyob T-hujayra terapiyasi platformasidan kelib chiqadigan uzoq muddatli daromadlar potentsiali bilan muvozanatga keltirmoqda. Valo foyda marjasi dinamikasi ushbu muvozanatni baholash imkonini beradi, bunda 46.10 belgisi ushbu parametrni tavsiflaydi. Shu bilan birga, TScan Therapeutics klinik sinovlarni qat'iy nazorat ostida shartnomaviy tadqiqot tashkilotlariga topshirish orqali operatsion xarajatlarni minimallashtirmoqda.

TCRX (tscan.com) Yalpi foyda bo'yicha rentabellik tarixi 04.07.2022dan 19.11.2026gacha

tscan.com (TCRX) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning asosiy tahlili:TScan Therapeutics (TCRX)
TScan Therapeutics tomonidan chiqariladigan mahsulotlar

Yalpi foyda bevosita ishlab chiqarish xarajatlarini qoplagandan keyin qolgan daromad qismini belgilaydi, bu esa investorlarga barqaror operatsion samaradorlikni tasodifiy moliyaviy sakrashlardan ajratish imkonini beradi. Qimmat onkologik tadqiqotlar va ishlanmalarga ( R&D ) e'tibor qaratgan TScan Therapeutics (TCRX) uchun hisoblangan yalpi foyda tijorat mahsulotlarining yo'qligi sababli nominal darajada qolmoqda, bu esa intensiv kapital sarfi bosqichini va biznesning tashqi moliyalashtirishga bog'liqligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik